HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Marieke Niesters Selected Research

Ketamine

4/2015Pharmacotherapy for pain: efficacy and safety issues examined by subgroup analyses.
3/2015Ketamine interactions with biomarkers of stress: a randomized placebo-controlled repeated measures resting-state fMRI and PCASL pilot study in healthy men.
2/2014Ketamine for chronic pain: risks and benefits.
1/2013Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131).
11/2012Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain.
10/2012Effect of subanesthetic ketamine on intrinsic functional brain connectivity: a placebo-controlled functional magnetic resonance imaging study in healthy male volunteers.
9/2012The dose-dependent effect of S(+)-ketamine on cardiac output in healthy volunteers and complex regional pain syndrome type 1 chronic pain patients.
8/2012Estimation of the contribution of norketamine to ketamine-induced acute pain relief and neurocognitive impairment in healthy volunteers.
11/2011Offset analgesia in neuropathic pain patients and effect of treatment with morphine and ketamine.
10/2011Absence of long-term analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: a randomized, prospective, double blind, active placebo-controlled trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Marieke Niesters Research Topics

Disease

21Pain (Aches)
12/2015 - 10/2010
8Neuralgia (Stump Neuralgia)
04/2015 - 07/2011
5Hyperalgesia
01/2014 - 07/2011
4Respiratory Insufficiency (Respiratory Failure)
04/2015 - 01/2012
2Fibromyalgia (Fibrositis)
12/2015 - 10/2011
2Hallucinations (Hallucination)
12/2015 - 02/2014
2Neoplasms (Cancer)
03/2013 - 10/2010
1Schizophrenia (Dementia Praecox)
12/2015
1Vomiting
02/2014
1Panic Disorder (Panic Attack)
02/2014
1Nausea
02/2014
1Inflammation
01/2014
1Drug-Induced Liver Injury
09/2011

Drug/Important Bio-Agent (IBA)

16KetamineFDA LinkGeneric
04/2015 - 10/2010
7N-Methylaspartate (NMDA)IBA
03/2015 - 10/2010
4Morphine (MS Contin)FDA LinkGeneric
01/2015 - 10/2010
4Opioid Analgesics (Opioids)IBA
07/2014 - 10/2010
2Fentanyl (Sublimaze)FDA LinkGeneric
04/2015 - 03/2013
2ErythropoietinFDA Link
01/2014 - 11/2011
2norketamineIBA
08/2012 - 07/2011
1Psychotropic Drugs (Psychoactive Drugs)IBA
12/2015
1Analgesics (Analgesic Drugs)IBA
04/2015
1Capsaicin (Zostrix)FDA Link
04/2015
13- (3- dimethylamino- 1- ethyl- 2- methylpropyl)phenolFDA Link
01/2015
1Biological Markers (Surrogate Marker)IBA
01/2015
1salicylhydroxamic acid (SHAM)IBA
08/2014
1Methadone (Dolophine)FDA LinkGeneric
03/2013
1insulin receptor-related receptor (IRR)IBA
01/2013
1Opioid Receptors (Opioid Receptor)IBA
01/2012
1Naloxone (Narcan)FDA LinkGeneric
01/2012
1Midazolam (Versed)FDA LinkGeneric
10/2011

Therapy/Procedure

9Analgesia
12/2015 - 10/2010
2Aftercare (After-Treatment)
01/2015 - 07/2011
1Drug Therapy (Chemotherapy)
04/2015
1Spinal Anesthesia
08/2014
1Intravenous Infusions
10/2011